Literature DB >> 22696769

Standardization of von Willebrand factor propeptide: value assignment to the WHO 6th IS Factor VIII/von Willebrand factor, plasma (07/316).

A R Hubbard1, M Hamill, H C J Eikenboom, R R Montgomery, K Mertens, S Haberichter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22696769      PMCID： PMC4196679          DOI： 10.1111/j.1538-7836.2012.04672.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  3 in total

1.  Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival.

Authors:  Sandra L Haberichter; Michael Balistreri; Pamela Christopherson; Patricia Morateck; Stefana Gavazova; Daniel B Bellissimo; Marilyn J Manco-Johnson; Joan Cox Gill; Robert R Montgomery
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

2.  Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD).

Authors:  Sandra L Haberichter; Giancarlo Castaman; Ulrich Budde; Ian Peake; Anne Goodeve; Francesco Rodeghiero; Augusto B Federici; Javier Batlle; Dominique Meyer; Claudine Mazurier; Jenny Goudemand; Jeroen Eikenboom; Reinhard Schneppenheim; Jorgen Ingerslev; Zdena Vorlova; David Habart; Lars Holmberg; Stefan Lethagen; John Pasi; Frank G H Hill; Robert R Montgomery
Journal:  Blood       Date:  2008-03-14       Impact factor: 22.113

3.  Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome.

Authors:  P J van Genderen; R C Boertjes; J A van Mourik
Journal:  Thromb Haemost       Date:  1998-09       Impact factor: 5.249
  3 in total
  3 in total

Review 1.  Diagnostic approach to von Willebrand disease.

Authors:  Christopher Ng; David G Motto; Jorge Di Paola
Journal:  Blood       Date:  2015-02-23       Impact factor: 22.113

Review 2.  What have we learned from large population studies of von Willebrand disease?

Authors:  Robert R Montgomery; Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality.

Authors:  Aurélien Philippe; Richard Chocron; Nicolas Gendron; Olivier Bory; Agathe Beauvais; Nicolas Peron; Lina Khider; Coralie L Guerin; Guillaume Goudot; Françoise Levasseur; Christophe Peronino; Jerome Duchemin; Julie Brichet; Elise Sourdeau; Florence Desvard; Sébastien Bertil; Frédéric Pene; Cherifa Cheurfa; Tali-Anne Szwebel; Benjamin Planquette; Nadia Rivet; Georges Jourdi; Caroline Hauw-Berlemont; Bertrand Hermann; Pascale Gaussem; Tristan Mirault; Benjamin Terrier; Olivier Sanchez; Jean-Luc Diehl; Michaela Fontenay; David M Smadja
Journal:  Angiogenesis       Date:  2021-01-15       Impact factor: 10.658
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.